Shandong Boan Biotechnology Co., Ltd. (HKG:6955)

HKG:6955 Financials Overview

Financials in millions CNY. Fiscal year is January - December.

Revenue & Profits

Chart

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Revenue Revenue Growth	784.82	784.82	726.32	618.13	515.96	158.7
Revenue Growth	3.71%	8.05%	17.50%	19.80%	225.11%	-
Gross Profit Gross Profit Growth	562.44	562.44	542.65	408.97	354.23	106.51
Operating Income Operating Income Growth	32.72	32.72	61.08	-129.93	-342.53	-221.27
Net Income Net Income Growth	7.14	7.14	73.19	-119.38	-331.75	-225.42
Earnings Per Share EPS Growth	0.01	0.01	0.14	-0.23	-0.67	-0.47
EPS Growth	-77.97%	-90.91%	-	-	-	-

Revenue by Geography

Chart

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Mainland China Mainland China Growth	747.63	747.63	726.32	618.13	515.96	158.7
Other Countries Other Countries Growth	37.19	37.19	-	-	-	-
Total Total Growth	784.82	784.82	726.32	618.13	515.96	158.7

Cash & Debt

Chart

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Investments Cash & Investments Growth	1,130	1,130	198.87	201.85	233.5	613.56
Total Debt Total Debt Growth	783.28	783.28	685.54	405.91	301.72	264.52
Net Cash (Debt) Net Cash Growth	347.13	347.13	-486.67	-204.06	-68.23	349.04
Net Cash Growth	-	-	-	-	-	-
Net Cash Per Share Net Cash Per Share Growth	0.60	0.60	-0.91	-0.40	-0.14	0.73

Cash Flow & CapEx

Chart

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Operating Cash Flow Operating Cash Flow Growth	64.89	64.89	-117.94	-18.57	-201.84	-246.28
Capital Expenditures CapEx Growth	-72.55	-72.55	-66.6	-67.32	-81.29	-107.73
Free Cash Flow Free Cash Flow Growth	-7.66	-7.66	-184.53	-85.89	-283.13	-354.01
Free Cash Flow Growth	-	-	-	-	-	-

Margins

Chart

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Gross Margin	71.66%	71.66%	74.71%	66.16%	68.66%	67.12%
Operating Margin	4.17%	4.17%	8.41%	-21.02%	-66.39%	-139.42%
Pretax Margin	0.91%	0.91%	10.08%	-19.31%	-64.30%	-142.04%
Profit Margin	0.91%	0.91%	10.08%	-19.31%	-64.30%	-142.04%
FCF Margin	-0.98%	-0.98%	-25.41%	-13.89%	-54.87%	-223.06%

Valuation

Chart

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug 1, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
PE Ratio	367.92	668.53	64.20	-	-	-
Forward PE	-	29.50	-	-	-	-
PS Ratio	3.35	6.09	6.47	11.59	17.29	-

Data Source: S&P Global Market Intelligence Last updated: Dec 31, 2025

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Jul 31, 2026

Data Sources Report a data error